Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Tao Synergies Inc. (TAOX : NSDQ)

• Company Description    Synaptogenix Inc. is an emerging biopharmaceutical company. It focused on developing therapies for neurodegenerative diseases. The company's lead therapeutic candidate consist Bryostatin-1. Synaptogenix Inc. is based in NEW YORK. Number of Employees: 5

• Price / Volume Information    Yesterday's Closing Price: $3.29 Daily Weekly Monthly 20 Day Moving Average: 86,513 shares Shares Outstanding: 7.47 (millions) Market Capitalization: $24.58 (millions) Beta: 1.42 52 Week High: $10.00 52 Week Low: $3.22 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.95% -3.66% 12 Week -35.87% -37.62% Year To Date -10.60% -7.85%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1185 Avenue of the Americas 3rd Floor - New York,NY 10036 USA ph: 973-242-0005 fax: - ir@taosynergies.com http://www.taosynergies.com

• General Corporate Information    Officers Joshua N. Silverman - Executive Chairman and Director Bruce T. Bernstein - Vice-Chairman Robert Weinstein - Chief Financial Officer; Secretary and Executive V William S. Singer - Director Robert Ephron - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-MISC SVCS Sector: Finance CUSIP: 87167T300 SIC: 6199 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/21/26 Share - Related Items Shares Outstanding: 7.47 Most Recent Split Date: 4.00 (0.04:1) Beta: 1.42 Market Capitalization: $24.58 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.06 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -1,250.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 322.65% ROE 06/30/26 - - 03/31/26 - -163.40 12/31/25 - -193.08 ROA 06/30/26 - - 03/31/26 - -133.47 12/31/25 - -144.93 Current Ratio 06/30/26 - - 03/31/26 - 27.39 12/31/25 - 13.99 Quick Ratio 06/30/26 - - 03/31/26 - 27.39 12/31/25 - 13.99 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - -3,635.47 12/31/25 - -9,611.04 Book Value 06/30/26 - - 03/31/26 - 3.11 12/31/25 - 2.83 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©